Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gin Hwa BiotechROCO:7806 22 OCF Yield % is 4.57 as of Jul. 22, 2026, which is 1% below its 10-year median of 4.61. GuruFocus rates ROCO:7806 with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 1,410 Biotechnology companies, Gin Hwa Biotech ranks better than 89.65% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Gin Hwa Biotech OCF Yield % Related Terms
Gin Hwa Biotech OCF Yield % Historical Data
* Premium members only.
The historical data trend for Gin Hwa Biotech's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7806 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, Gin Hwa Biotech's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gin Hwa Biotech OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gin Hwa Biotech's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Gin Hwa Biotech's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gin Hwa Biotech (ROCO:7806) has a OCF Yield % of 4.57 as of Jul. 22, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gin Hwa Biotech and its competitors. This is near median its historical median of 4.61. Over the past decade, Gin Hwa Biotech's OCF Yield % has ranged from 3.95 to 5.86. According to the industry distribution chart, Gin Hwa Biotech ranks #146 out of 1410 companies in the Biotechnology industry, placing it in the top 10.4%.
Is Gin Hwa Biotech's OCF Yield % too high?
Gin Hwa Biotech's current OCF Yield % of 4.57 is near median its 10-year median of 4.61. Over the past 10 years, this metric has ranged from a low of 3.95 to a high of 5.86. Based on the distribution chart, Gin Hwa Biotech ranks #146 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Gin Hwa Biotech has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Gin Hwa Biotech's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gin Hwa Biotech ranks #146 out of 1410 companies for OCF Yield %. This places Gin Hwa Biotech in the top 10% of its industry — outperforming the majority of peers. Historically, Gin Hwa Biotech's own OCF Yield % has ranged from 3.95 to 5.86 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Gin Hwa Biotech and its competitors. Gin Hwa Biotech's current OCF Yield % is 4.57, which is near median its own 10-year median of 4.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gin Hwa Biotech stock overvalued right now?
Gin Hwa Biotech (ROCO:7806) has a current OCF Yield % of 4.57. The current OCF Yield % is 4.57, which is near median its 10-year median of 4.61. Gin Hwa Biotech's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Gin Hwa Biotech (ROCO:7806), the current OCF Yield % is 4.57 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gin Hwa Biotech Inc is engaged in developing completely original products to achieve every vision. Its Services and technology are Product Development, OEM Service, Core Technology, R & D Center, Professional Production, and Others.
22GF Score
Get the complete analysis for ROCO:7806
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7806 has been successfully added to your 
